Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant DENV-2 Protein prM/prM Protein, N-GST & C-His

Catalog #:   YVV25302 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P07564
Protein length: Gly122-Arg205
Overview

Catalog No.

YVV25302

Expression system

E. coli

Species

Dengue virus type 2 (strain Jamaica/1409/1983) (DENV-2)

Protein length

Gly122-Arg205

Predicted molecular weight

37.74 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P07564

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% SKL, 1mM EDTA, 5% Trehalose, 5% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Genome polyprotein, Protein prM, Precursor membrane protein

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant DENV-2 Protein prM/prM Protein
References

Antiviral in vitro activity of a novel dichlorinated tyrosine methyl ester derivative against the infection of two flaviviruses of public health concern, dengue and zika virus., PMID:40450991

Clinico-genomic study reveals association of dengue virus genome high frequency mutations with dengue disease severity., PMID:40436903

Role of c-ABL in DENV-2 Infection and Actin Remodeling in Vero Cells., PMID:40362443

Design, synthesis and biological evaluation of dapsone derivatives with broad-spectrum antiviral activity., PMID:40344737

A novel immunogen comprising a bc loop and mutant fusion loop epitopes generates potent neutralization and protective abilities against flaviviruses without risk of disease enhancement., PMID:40339178

Characterization of serotype-specific Dengue virus T cell inhibition., PMID:40336275

Genomic hotspots in the DENV-2 serotype (E, NS4B, and NS5 genes) are associated with dengue disease severity in the endemic region of India., PMID:40299925

Complete genome sequence of dengue virus serotype 2 obtained from Chattogram, Bangladesh., PMID:40243309

Integrated serological surveillance for neglected tropical diseases, vaccine-preventable diseases, and arboviruses in Samoa, 2018., PMID:40221582

The epidemiology and identification of risk factors associated with severe dengue during the 2023 dengue outbreak in Kaohsiung City, Taiwan., PMID:40220842

Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa., PMID:40207881

Efficacy, Immune Response, and Safety of Dengue Vaccines in Adolescents: A Systematic Review., PMID:40195054

Characterization of dengue patients in Vietnam: Clinical, virological, and IL-10 profiles during 2021- 2022 outbreaks., PMID:40153381

Epidemiological and molecular typing of dengue viruses circulating in Jorhat district, Assam, India., PMID:40132676

Prevalence and Circulating Serotypes of Dengue in Bastar, Chhattisgarh: A Cross-Sectional Study., PMID:40123828

Cytoplasmic retention of dengue virus capsid protein by metformin impairing nuclear transport., PMID:40111383

Identification and evaluation of bioactive compounds from Azadirachta indica as potential inhibitors of DENV-2 capsid protein: An integrative study utilizing network pharmacology, molecular docking, molecular dynamics simulations, and machine learning techniques., PMID:40051864

Broad-spectrum antiviral ferruginol analog affects the viral proteins translation and actin remodeling during dengue virus infection., PMID:40043781

Darunavir inhibits dengue virus replication by targeting the hydrophobic pocket of the envelope protein., PMID:40024350

Dengue dynamics in Bali: Serotype shifts, genotype replacement and multiple virus lineage circulation in the last 10 years., PMID:40008453

miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., PMID:39976655

Investigation of severe dengue outbreak in Maumere, East Nusa Tenggara, Indonesia: Clinical, serological, and virological features., PMID:39965014

RT-RPA Assisted CRISPR/Cas12a Based One-Pot Rapid and Visual Detection of the Pan-Dengue Virus., PMID:39949262

Conventional and antibody-enhanced DENV infection of human macrophages induces differential immunotranscriptomic profiles., PMID:39902963

Comparison of clinical and virological features in pediatric and adult dengue cases at Insein General Hospital during Myanmar's 2022 dengue season., PMID:39881372

Achievements and Approaches in the Search for Small-Molecule Dengue NS2B/NS3 Inhibitors., PMID:39871573

Simultaneous detection of dengue virus serotypes in a dual-serotype-detection nucleic acid based lateral flow assay., PMID:39798241

The Compound AT13148 Targeting AKT Suppresses Dengue Virus 2 Replication., PMID:39772930

Discovery of Potent Dengue Virus NS2B-NS3 Protease Inhibitors Among Glycyrrhizic Acid Conjugates with Amino Acids and Dipeptides Esters., PMID:39772233

E2 Ubiquitin-Conjugating Enzymes Regulates Dengue Virus-2 Replication in Aedes albopictus., PMID:39770712

Clinical characteristics of dengue virus infections in Karachi from 2019 to 2023: a cross-sectional study., PMID:39738341

Trends in dengue virus positivity & serotyping in Rajasthan., PMID:39737514

The importance of paying attention to the role of lipid-lowering drugs in controlling dengue virus infection., PMID:39702248

Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains., PMID:39700304

Significance of diagnostic and therapeutic potential of serum endothelial and inflammatory biomarkers in defining disease severity of dengue infected patients., PMID:39674822

In silico exploration of potent flavonoids for dengue therapeutics., PMID:39666626

Dominance of dengue virus serotype-2 in Pakistan (2023-2024): Molecular characterization of the envelope gene and exploration of antiviral targets., PMID:39557198

Computational identification of Vernonia cinerea-derived phytochemicals as potential inhibitors of nonstructural protein 1 (NSP1) in dengue virus serotype-2., PMID:39474614

Possible effects of ancestry-related oxysterol-binding protein-like 10 genetic polymorphisms on dengue virus replication and anti-dengue immune response., PMID:39444395

Long term T cell response and safety of a tetravalent dengue vaccine in healthy children., PMID:39420169

A Serological Multiplexed Immunoassay (MIA) Detects Antibody Reactivity to SARS-CoV-2 and Other Viral Pathogens in Liberia and Is Configurable as a Multiplexed Inhibition Test (MINT)., PMID:39391865

Genomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir., PMID:39384752

Soluble isoforms of the DC-SIGN receptor can increase the dengue virus infection in immature dendritic cells., PMID:39341603

Small extracellular vesicles from the human endothelial cell line EA.hy 926 exert a self-cell activation and modulate DENV-2 genome replication and infection in naïve endothelial cells., PMID:39325758

Cordycepin exhibits both antiviral and anti-inflammatory effects against dengue virus infection., PMID:39262808

Effects of the oxoaporphine alkaloid hernandonine on dengue virus. Evidence for its mechanisms of action., PMID:39232285

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2., PMID:39227969

Exploring antiviral activity of Betanin and Glycine Betaine against dengue virus type-2 in transfected Hela cells., PMID:39214424

Evaluation of Four Humanized NOD-Derived Mouse Models for Dengue Virus-2 Infection., PMID:39204240

Commercial Enzyme-Linked Immunosorbent Assay Kit Is Useful for Detection of Recombinant and Secretory Nonstructural-1 Protein Antigen of Dengue Virus., PMID:39134458

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant DENV-2 Protein prM/prM Protein, N-GST & C-His [YVV25302]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only